1
|
Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial.
|
Lancet Oncol
|
2012
|
1.95
|
2
|
Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor.
|
J Clin Oncol
|
2008
|
1.92
|
3
|
High-risk populations identified in Childhood Cancer Survivor Study investigations: implications for risk-based surveillance.
|
J Clin Oncol
|
2009
|
1.68
|
4
|
Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma.
|
J Neurooncol
|
2005
|
1.44
|
5
|
Temozolomide after radiotherapy for newly diagnosed high-grade glioma and unfavorable low-grade glioma in children.
|
J Neurooncol
|
2006
|
1.38
|
6
|
Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1.
|
Proc Natl Acad Sci U S A
|
2013
|
1.33
|
7
|
Imaging characteristics of atypical teratoid-rhabdoid tumor in children compared with medulloblastoma.
|
AJR Am J Roentgenol
|
2008
|
1.27
|
8
|
Late-occurring neurologic sequelae in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.
|
J Clin Oncol
|
2009
|
1.23
|
9
|
Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98).
|
Cancer
|
2005
|
1.12
|
10
|
Utility of apparent diffusion coefficient ratios in distinguishing common pediatric cerebellar tumors.
|
Acad Radiol
|
2012
|
1.01
|
11
|
Altered irinotecan pharmacokinetics in pediatric high-grade glioma patients receiving enzyme-inducing anticonvulsant therapy.
|
Clin Cancer Res
|
2002
|
1.01
|
12
|
Pediatric oligodendrogliomas: a study of molecular alterations on 1p and 19q using fluorescence in situ hybridization.
|
J Neuropathol Exp Neurol
|
2003
|
0.98
|
13
|
Reply to "survival analysis for apparent diffusion coefficient measures in children with embryonal brain tumors," by Grech-Sollars et al.
|
Neuro Oncol
|
2012
|
0.96
|
14
|
Radiation, atherosclerotic risk factors, and stroke risk in survivors of pediatric cancer: a report from the Childhood Cancer Survivor Study.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.95
|
15
|
Common pediatric cerebellar tumors: correlation between cell densities and apparent diffusion coefficient metrics.
|
Radiology
|
2013
|
0.93
|
16
|
Predictors of tumor progression among children with gangliogliomas. Clinical article.
|
J Neurosurg Pediatr
|
2009
|
0.90
|
17
|
Applicability of apparent diffusion coefficient ratios in preoperative diagnosis of common pediatric cerebellar tumors across two institutions.
|
Neuroradiology
|
2014
|
0.89
|
18
|
Childhood medulloblastoma: current status of biology and treatment.
|
CNS Drugs
|
2010
|
0.87
|
19
|
Intermediate grade meningeal melanocytoma of cervical spine.
|
Childs Nerv Syst
|
2009
|
0.87
|
20
|
Proliferative and metabolic markers in incompletely excised pediatric pilocytic astrocytomas--an assessment of 3 new variables in predicting clinical outcome.
|
Neuro Oncol
|
2011
|
0.85
|
21
|
Safety and efficacy of repeated monthly carboplatin desensitization.
|
J Allergy Clin Immunol
|
2004
|
0.80
|
22
|
Optic nerve tumor in tuberous sclerosis complex is not responsive to sirolimus.
|
Pediatr Neurol
|
2010
|
0.79
|
23
|
Predictive value of interleukin-5 and monocyte chemotactic protein-1 for bacteremia in children with febrile neutropenia.
|
J Pediatr Hematol Oncol
|
2012
|
0.77
|
24
|
Rhabdoid tumors in a shared parental environment.
|
Pediatr Blood Cancer
|
2006
|
0.77
|
25
|
Accidental overdose of intrathecal cytarabine in children.
|
Ann Pharmacother
|
2013
|
0.77
|
26
|
Primary renal lymphoma presenting with hypertension.
|
Pediatr Blood Cancer
|
2007
|
0.76
|
27
|
Effect of intrapatient dosage escalation of irinotecan on its pharmacokinetics in pediatric patients who have high-grade gliomas and receive enzyme-inducing anticonvulsant therapy.
|
Cancer
|
2003
|
0.75
|
28
|
Low-grade bone lesions in survivors of childhood medulloblastoma/primitive neuroectodermal tumor.
|
Acad Radiol
|
2011
|
0.75
|